{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:09:42Z","timestamp":1789664982530,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,7]]},"DOI":"10.7759\/cureus.53779","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T19:37:02Z","timestamp":1707334622000},"source":"Crossref","is-referenced-by-count":1,"title":["Tamoxifen- and Triptorelin-Induced Major Hypertriglyceridemia: A Case Report"],"prefix":"10.7759","author":[{"given":"Widad","family":"Moussaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Zahra","family":"Lahmamssi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayat","family":"Aynaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Salhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"El Ouahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/2050640618755002","article-title":"Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management","volume":"6","author":"de Pretis N","year":"2018","unstructured":"de Pretis N, Amodio A, Frulloni L. Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management. United European Gastroenterol J. 2018, 6:649-55. 10.1177\/2050640618755002","journal-title":"United European Gastroenterol J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13279","article-title":"Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia","volume":"25","author":"Yoneyama K","year":"2019","unstructured":"Yoneyama K, Nakagawa M. Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia. Breast J. 2019, 25:788-9. 10.1111\/tbj.13279","journal-title":"Breast J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.5.4753","article-title":"Effect of tamoxifen on serum lipid metabolism","volume":"83","author":"Hozumi Y","year":"1998","unstructured":"Hozumi Y, Kawano M, Saito T, Miyata M. Effect of tamoxifen on serum lipid metabolism. J Clin Endocrinol Metab. 1998, 83:1633-5. 10.1210\/jcem.83.5.4753","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108677","article-title":"Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase","volume":"59","author":"Applebaum DM","year":"1977","unstructured":"Applebaum DM, Goldberg AP, Pyk\u00e4list\u00f6 OJ, Brunzell JD, Hazzard WR. Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase. J Clin Invest. 1977, 59:601-8. 10.1172\/JCI108677","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.15.11404","article-title":"Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter","volume":"275","author":"Homma H","year":"2000","unstructured":"Homma H, Kurachi H, Nishio Y, et al.. Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J Biol Chem. 2000, 275:11404-11. 10.1074\/jbc.275.15.11404","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860601)57:11<2123::aid-cncr2820571106>3.0.co;2-2","article-title":"Severe lipemia induced by tamoxifen","volume":"57","author":"Brun LD","year":"1986","unstructured":"Brun LD, Gagn\u00e9 C, Rousseau C, Moorjani S, Lupien PJ. Severe lipemia induced by tamoxifen. Cancer. 1986, 57:2123-6. 10.1002\/1097-0142(19860601)57:11&lt;2123::aid-cncr2820571106&gt;3.0.co;2-2","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0936-6555(98)80019-8","article-title":"Severe hypertriglyceridaemia and hypercholesterolaemia associated with tamoxifen use","volume":"10","author":"Colls BM","year":"1998","unstructured":"Colls BM, George PM. Severe hypertriglyceridaemia and hypercholesterolaemia associated with tamoxifen use. Clin Oncol (R Coll Radiol). 1998, 10:270-1. 10.1016\/s0936-6555(98)80019-8","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath H","year":"2012","unstructured":"Chatrath H, Vuppalanchi R, Chalasani N. Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin Liver Dis. 2012, 32:22-9. 10.1055\/s-0032-1306423","journal-title":"Semin Liver Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-021-00780-z","article-title":"A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time","volume":"21","author":"Isobe H","year":"2021","unstructured":"Isobe H, Shimoda M, Kan Y, et al.. A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time. BMC Endocr Disord. 2021, 21:115. 10.1186\/s12902-021-00780-z","journal-title":"BMC Endocr Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800740714","article-title":"Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen","volume":"74","author":"Noguchi M","year":"1987","unstructured":"Noguchi M, Taniya T, Tajiri K, et al.. Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen. Br J Surg. 1987, 74:586-7. 10.1002\/bjs.1800740714","journal-title":"Br J Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008309613082","article-title":"Tamoxifen-induced severe hypertriglyceridemia and pancreatitis","volume":"11","author":"Elisaf MS","year":"2000","unstructured":"Elisaf MS, Nakou K, Liamis G, Pavlidis NA. Tamoxifen-induced severe hypertriglyceridemia and pancreatitis. Ann Oncol. 2000, 11:1067-9. 10.1023\/a:1008309613082","journal-title":"Ann Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2002.14.3.309","article-title":"Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer","volume":"14","author":"Artac M","year":"2002","unstructured":"Artac M, Sari R, Altunbas H, Karayalcin U. Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer. J Chemother. 2002, 14:309-11. 10.1179\/joc.2002.14.3.309","journal-title":"J Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1023\/b:ddas.0000034561.37401.f2","article-title":"Tamoxifen-induced severe acute pancreatitis: a case report","volume":"49","author":"Lin HH","year":"2004","unstructured":"Lin HH, Hsu CH, Chao YC. Tamoxifen-induced severe acute pancreatitis: a case report. Dig Dis Sci. 2004, 49:997-9. 10.1023\/b:ddas.0000034561.37401.f2","journal-title":"Dig Dis Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200626050-00007","article-title":"Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis","volume":"26","author":"Alagozlu H","year":"2006","unstructured":"Alagozlu H, Cindoruk M, Unal S. Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis. Clin Drug Investig. 2006, 26:297-302. 10.2165\/00044011-200626050-00007","journal-title":"Clin Drug Investig"},{"key":"ref15","article-title":"Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with positive rechallenge","volume":"11","author":"Sakhri J","year":"2010","unstructured":"Sakhri J, Ben Salem C, Harbi H, Fathallah N, Ltaief R. Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with positive rechallenge. JOP. 2010, 11:382-4.","journal-title":"JOP"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.44.745","article-title":"Severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery","volume":"44","author":"Hozumi Y","year":"1997","unstructured":"Hozumi Y, Kawano M, Miyata M. Severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery. Endocr J. 1997, 44:745-9. 10.1507\/endocrj.44.745","journal-title":"Endocr J"},{"key":"ref17","article-title":"Hypertriglyc\u00e9rid\u00e9mie majeure sous tamoxif\u00e8ne","volume":"13","author":"Khabbal Y","year":"2012","unstructured":"Khabbal Y, El Ouahabi H, Bensbaa S, Agerd L, Brahmi S, El Mesbahi O, Ajdi F. Hypertriglyc\u00e9rid\u00e9mie majeure sous tamoxif\u00e8ne. Pan Afr Med J. 2012, 13:68.","journal-title":"Pan Afr Med J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(96)02698-7","article-title":"Long-acting triptorelin for the treatment of endometriosis","volume":"54","author":"Choktanasiri W","year":"1996","unstructured":"Choktanasiri W, Boonkasemsanti W, Sittisomwong T, Kunathikom S, Suksompong S, Udomsubpayakul U, Rojanasakul A. Long-acting triptorelin for the treatment of endometriosis. Int J Gynaecol Obstet. 1996, 54:237-43. 10.1016\/0020-7292(96)02698-7","journal-title":"Int J Gynaecol Obstet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60656-3","article-title":"Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis","volume":"375","author":"Jun M","year":"2010","unstructured":"Jun M, Foote C, Lv J, et al.. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet. 2010, 375:1875-84. 10.1016\/S0140-6736(10)60656-3","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5688(15)30001-5","article-title":"A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy","volume":"19","author":"Aguiar C","year":"2015","unstructured":"Aguiar C, Alegria E, Bonadonna RC, et al.. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy. Atheroscler Suppl. 2015, 19:1-12. 10.1016\/S1567-5688(15)30001-5","journal-title":"Atheroscler Suppl"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pranut.2020.06.010","article-title":"Hypertriglyc\u00e9rid\u00e9mies, d\u00e9marche clinique et th\u00e9rapeutique","volume":"16","author":"Lecerf JM","year":"2020","unstructured":"Lecerf JM. Hypertriglyc\u00e9rid\u00e9mies, d\u00e9marche clinique et th\u00e9rapeutique. Pratiques en nutrition. 2020, 16:42-6. 10.1016\/j.pranut.2020.06.010","journal-title":"Pratiques en nutrition"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-014-3968-6","article-title":"n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial","volume":"50","author":"Hedengran A","year":"2015","unstructured":"Hedengran A, Szecsi PB, Dyerberg J, Harris WS, Stender S. n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial. Lipids. 2015, 50:165-75. 10.1007\/s11745-014-3968-6","journal-title":"Lipids"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.12.1585","article-title":"Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial","volume":"285","author":"Robins SJ","year":"2001","unstructured":"Robins SJ, Collins D, Wittes JT, et al.. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA. 2001, 285:1585-91. 10.1001\/jama.285.12.1585","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and triglyceride levels in familial chylomicronemia syndrome","volume":"381","author":"Witztum JL","year":"2019","unstructured":"Witztum JL, Gaudet D, Freedman SD, et al.. Volanesorsen and triglyceride levels in familial chylomicronemia syndrome. N Engl J Med. 2019, 381:531-42. 10.1056\/NEJMoa1715944","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2017.08.003","article-title":"Apolipoprotein C-III inhibition with volanesorsen in patients with hypertriglyceridemia (COMPASS): a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Gouni-Berthold I","year":"2017","unstructured":"Gouni-Berthold I, Alexander V, Digenio A, et al.. Apolipoprotein C-III inhibition with volanesorsen in patients with hypertriglyceridemia (COMPASS): a randomized, double-blind, placebo-controlled trial. Atheroscler Suppl. 2017, 28:e1-2. 10.1016\/j.atherosclerosissup.2017.08.003","journal-title":"Atheroscler Suppl"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1016\/j.nupar.2020.12.002","article-title":"Hypertriglyc\u00e9rid\u00e9mies majeures: diagnostic et prise en charge","volume":"35","author":"Charri\u00e8re S","year":"2021","unstructured":"Charri\u00e8re S. Hypertriglyc\u00e9rid\u00e9mies majeures: diagnostic et prise en charge. Nutr Clin Metab. 2021, 35:77-84.","journal-title":"Nutr Clin Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/177979-tamoxifen--and-triptorelin-induced-major-hypertriglyceridemia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:17:46Z","timestamp":1707509866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/177979-tamoxifen--and-triptorelin-induced-major-hypertriglyceridemia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.53779","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,7]]}}}